HCA Healthcare Q2 2023 revenue $15.86B; EPS $4.29; raises 2023 guidance

HCA Healthcare, Inc.

2023-Q2 EPS reported $9.14 revenue$31,452,000,000

Revenue $15.861B, up 7% YoY; net income $1.193B, diluted EPS $4.29 (vs $3.90).
Adjusted EBITDA $3.056B; same facility admissions +2.2%, equivalent admissions +3.7%.
2023 guidance raised: revenue $63.25-$64.75B, EPS $17.70-$18.90.
Quarterly dividend $0.60/share, payable Sept 29 to holders of record Sept 15.
Repurchased 3.3M shares for $915M in Q2; $2.825B remaining authorization.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.